BioSpace News Archive

GI OnDEMAND ®, gastroenterology’s leading multidisciplinary virtual integrated care platform announced a partnership with Mindset Health, the creator of Nerva, a 6-week gut-directed hypnotherapy program, delivered through a mobile app to help patients with irritable bowel syndrome better manage their symptoms.

Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA® , will announce financial results for the third quarter ended September 30, 2022 on Thursday, November 3, 2022, after market close.

U.S. Patent No. 11,471,431 relates to the use of LP-300 to increase the survival time of patients with cancers overexpressing thioredoxin or glutaredoxin.

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the third quarter ended September 30, 2022, after the market closes on Monday, November 7, 2022.

Tremeau Pharmaceuticals to Host Key Opinion Leader Webinar on Rofecoxib in Migraine Management on Tuesday, October 25th.

PharmaEssentia USA Corporation announced the recent appointment of three new female executives to the company’s U.S. leadership team.

Venatorx Pharmaceuticals today will present new data during IDWeek 2022 for its novel investigational antibiotic cefepime-taniborbactam.

Peptilogics is presenting two posters featuring preclinical data from its antimicrobial peptide, PLG0206, at ID Week 2022.

Revance Therapeutics, Inc. today announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for DAXXIFY™ for the treatment of cervical dystonia.

Bausch Health Companies Inc. today announced the presentation of eleven posters during the Fall Clinical Dermatology Conference, which takes place Oct. 20-23, 2022 in Las Vegas, Nev.